| Literature DB >> 34084738 |
Marcelo Vieira da Costa Almeida1, Antonio C Moura1, Lúcia Santos1, Luciana Gominho2, Ully Dias Nascimento Távora Cavalcanti1, Kaline Romeiro1.
Abstract
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) corresponds to an adverse effect of the use of drugs such as bisphosphonates and denosumab. This condition is often associated with pain, infection, purulent secretion, paraesthesia, tooth mobility and halitosis, decreasing the patient's quality of life. The management of MRONJ tends to be conservative, through the guidance of oral hygiene, antibiotic therapy and mouthwashes. However, the use of antimicrobial photodynamic therapy (aPDT) has shown promise in the treatment of these injuries. The purpose of this article is to report a case of MRONJ treatment associated with aPDT. Case Report: A 75-year-old patient, with a history of breast cancer and use of intravenous Zoledronic Acid, presented with bilateral MRONJ lesions in tuberosity on the right and left sides. Treatment was conservatively instituted with the use of aPDT as an adjuvant. After 12 aPDT sessions, complete regression of the lesion was observed. However, after two weeks, the presence of a new lesion was noted, this time in the anterior region of the maxilla. The same protocol previously established was followed and after two aPDT sessions, the patient returned with complete lesion regression.Entities:
Keywords: Bisphosphonates; Low-level laser therapy; MRONJ; Photobiomodulation; Photodynamic therapy
Year: 2021 PMID: 34084738 PMCID: PMC8164899 DOI: 10.34172/jlms.2021.12
Source DB: PubMed Journal: J Lasers Med Sci ISSN: 2008-9783